Mode
Text Size
Log in / Sign up

Complete surgical excision of renal solitary fibrous tumors is associated with favorable clinical outcomesSurgical Removal Shows Favorable Outcomes for Renal Solitary Fibrous Tumors

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that complete surgical excision with negative margins is associated with favorable outcomes for renal solitary fibrous tumors.

This narrative review explores the clinical presentation, diagnosis, and management of primary renal solitary fibrous tumors. The authors synthesize findings from case reports and series to describe these tumors as well-circumscribed masses that often present as asymptomatic flank pain or hematuria. Histopathological hallmarks include spindle-cell proliferation and diffuse nuclear expression of STAT6.

The review highlights that complete surgical excision with negative margins is associated with favorable outcomes in the majority of patients. However, approximately 10-15% of cases may develop recurrence or distant metastasis, necessitating long-term surveillance due to the potential for delayed recurrence.

A primary limitation noted by the authors is the limited data available regarding the management of advanced disease. While targeted or anti-angiogenic agents are mentioned as options for advanced cases, their specific efficacy is not quantified in this review. Clinical practice should emphasize histopathological examination and prolonged follow-up to manage potential late recurrences.

How this fits prior evidence

This narrative review addresses a gap in the management of renal solitary fibrous tumors by emphasizing the role of STAT6 expression in diagnosis and the necessity of long-term surveillance. It does not relate to previously covered topics regarding colorectal cancer metastasis patterns or immune checkpoint inhibitors.

Renal solitary fibrous tumors are rare growths that typically start in the kidney capsule or sinus. These tumors are often found without symptoms, though some patients may experience flank pain or blood in the urine. Doctors use imaging and specific tissue tests, such as STAT6 expression, to identify these masses accurately.

Research shows that complete surgical removal with clear margins leads to favorable outcomes for most patients. However, because these tumors can reappear late, long-term monitoring is necessary. About 10% to 15% of cases may see the tumor return or spread to other parts of the body over time.

While surgery is a primary treatment, there is currently limited data regarding the use of targeted or anti-angiogenic drugs for advanced cases. Because this information comes from a narrative review of case reports, the evidence for advanced treatments is not yet fully established. Patients should work with their doctors to manage long-term follow-up care.

What this means for you:
Complete surgical removal is effective for most patients, but long-term monitoring is needed due to recurrence risks.

Common questions

What is the success rate of surgery for these tumors?

Complete surgical excision with negative margins is associated with favorable outcomes in the majority of patients. However, about 10% to 15% of cases may still develop a recurrence or distant metastasis, making long-term surveillance important.

Are these tumors usually easy to detect?

These tumors are frequently asymptomatic, meaning they often do not cause symptoms. When they do cause issues, they may present as flank pain or hematuria (blood in the urine).

What happens if the disease is advanced?

For patients with advanced disease, targeted or anti-angiogenic agents may be used. However, there is currently limited data to confirm how well these specific medications work for advanced cases.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
PurposeRenal solitary fibrous tumor is a rare mesenchymal neoplasm with heterogeneous biological behavior. This review summarizes current evidence regarding its epidemiology, diagnosis, treatment, and clinical outcomes to support clinical management.MethodsPubMed and Web of Science were searched from database inception to September 10, 2025, for studies involving renal solitary fibrous tumors. Eligible studies included case reports, case series, and original articles providing patient-level data on clinically and histologically confirmed primary renal solitary fibrous tumors.ResultsRenal solitary fibrous tumors commonly originate from the renal capsule or sinus and are frequently asymptomatic, although flank pain and hematuria may occasionally be present. Diagnostically, imaging typically reveals a well-circumscribed mass with variable enhancement patterns; however, histopathological examination remains essential for definitive diagnosis, characterized by spindle-cell proliferation and diffuse nuclear expression of STAT6. Therapeutically, complete surgical excision with negative margins constitutes the mainstay of treatment and is associated with favorable outcomes in the majority of patients. Nevertheless, approximately 10–15% of cases may develop recurrence or distant metastasis, underscoring the necessity of long-term surveillance. In the setting of advanced disease, limited data suggest that metastasectomy and selected targeted or anti-angiogenic agents may offer therapeutic benefit.ConclusionAccurate diagnosis requires integrated clinical, radiologic, and pathologic evaluation. Complete resection remains the cornerstone of treatment, while prolonged follow-up is recommended because of the potential for delayed recurrence. Further molecular studies and collaborative investigations are needed to optimize risk stratification and therapeutic strategies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.